Metal-based catalysts can be designed to activate prodrugs or generate toxic species within cancer cells. For instance, platinum-based drugs like cisplatin form cross-links with DNA, disrupting replication and leading to cell death. Recent research has explored using gold nanoparticles as catalysts to trigger the release of therapeutic agents directly within tumors.
